References
- Hamlyn J M, Ringel R, Schaeffer J, Levinson P D, Hamilton B P, Kowarski A A, Blaustein M P. A circulating inhibitor of (Na,K)ATPase associated with essential hypertension. Nature 1982; 300: 650–652
- De Wardener H E, MacGregor G A. The relation of a Circulating Sodium Transport Inhibitor (the Natriuretic Hormone?)to Hypertension. Medicine 1983; 62: 310–326
- Illescas M, Ricote M, Mendez E, G-Robles R, Sancho J. Complete purification of two identical Na(+)-pump inhibitors isolated from bovine hypothalamus and hypophysis. FEBS Lett 1990; 261: 436–440
- Sancho J M, García-Martín E, García-Robles R, Santirso R, Villa E, Gutiérrez-Merino C, Ricote M. Properties of the purified hypothalamic pituitary Na/K-ATPase inhibitor. J Cardiov Pharmacol 1993; 22(Suppl2.)S32–S34
- Montero A, Rodriguez-Barbero A, Ricote M, Sancho J, Lopez-Novoa J M. Effect of ouabain and hypothalamic,hypophysary inhibitory factor on rat messangial cell proliferation. J Cardiov Pharmacol 1993; 22(Suppl.2)35–37
- Rodriguez-Barbero A, Martinez-Salgado C, Rodriguez-Lopez A M, Ricote M, Sancho J, Lopez-Novoa J M. Effect of hypothalamic-hypophysary inhibitory factor on mesangial cell activation. Hypertension 1996; 26: 905–911, [part1]
- Ricote M, García-Martín E, Sancho J, Gutiérrez-Merino C. Modulation of the Ca2+pump by the Hypothalamic Hypophysary Inhibitory Factor. Hypertension 1995; 25: 365–371
- Ricote M, García-Martín E, Sancho J, Gutiérrez-Merino C. Modulation of the Ca,Mg-ATPase of sarcoplasmic reticulum by the hypothalamic hypophy-seal inhibitory factor. Biochem Biophys Acta 1995; 1232: 217–224
- Ricote M, García-Martín E, Sancho J, Gutiérrez-Merino C. Hypothalamic hypophyseal inhibitory factor (HHIF) increases intrasynaptosomal free calcium concentration. Hypertension 1997; 29: 1337–1343
- Huang B S, Sancho J M, García-Robles R, Leenen F H. Sympathoexcitatory effect of hypothalamic/hypophysary inhibitory factor in rats. Hypertension 1997; 29: 1291–1295
- Hamlyn J M, Blaustein M P, Bova S, DuCharme D W, Harris D W, Mandel F, Mathews W R, Ludens J H. Identification and characterization of a ouabain-like compound fron human plasma. Proc Natl Acad Sci USA 1991; 88: 6259–6263
- Mathews W R, DuCharme D W, Hamlyn J M, Harris D W, Mandel F, Clark M A, Ludens J H. Mass spectral characterization of an endogenous digitalis-like factor from human plasma. Hypertension 1991; 17: 930–935
- Tymiak A A, Norman J A, Bolgar M, DiDonato G C, Lee H, Parker W L, Lo L-C, Berova N, Nakanishi K, Haber E, Haupert G T, Jr. Physiochemical characterization of a ouabain isomer isolated from bovine hypothalamus. Proc Natl Acad Sci USA 1993; 90: 8189–8193
- Leenen F H, Harmsen E, Yu H, Ou C. Effects of dietary sodium on central and peripheral ouabain-like activity in spontaneously hypertensive rats. Am J Physiol 1993; 264: H2051–H2055
- Cantiello H F, Chen E, Ray S, Haupert G T, Jr. Na+pump in renal tubular cells is regulated by endogenous Na+-K+-ATPase inhibitor from hypothalamus. Am J Physiol 1988; 255: F574–F580
- Ludens J H, Clark M A, Robinson F G, DuCharme D W. Rats adrenal cortex is a source of a circulating ouabainlike compound. Hypertension 1992; 19: 721–724
- Haber E, Haupert G T, Jr. The search for a hypothalamic Na+,K+-ATPase inhibitor. Hypertension 1987; 9: 315–324